Evidence map›Paper›PMID 30484823›Full record

ArticleJAMA dermatology2019

Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.

Zoë C Venables, Philippe Autier, Tamar Nijsten, Kwok F Wong, Sinéad M Langan, Brian Rous, John Broggio, Catherine Harwood, Katherine Henson, Charlotte M Proby and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 156 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Prognostic determinants of overall, disease-specific and recurrence-free survival in cutaneous squamous cell carcinoma of the head and neck: a single-centre retrospective cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Zoë C VenablesNational Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
Philippe AutierInternational Prevention Research Institute, Lyon, France.
Tamar NijstenDepartment of Dermatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Kwok F WongNational Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
Sinéad M LanganLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
Brian RousNational Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
John BroggioNational Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
Catherine HarwoodBlizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom.
Katherine HensonNational Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
Charlotte M ProbyDepartment of Dermatology, School of Medicine, University of Dundee, Dundee, Scotland.
Jem RashbassNational Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
Irene M LeighBarts and The London School of Medicine and Dentistry, London, United Kingdom.
National Cancer Registration Service · GBPublic Health England · GBErasmus MC · NLInternational Prevention Research Institute · FRLondon School of Hygiene & Tropical Medicine · GBQueen Mary University of London · GBUniversity of Dundee · GB

Funding

Cancer Research UK 13044Wellcome Trust 205039/Z/16/Z
6 · The paper itself

Abstract

Importance: Cutaneous squamous cell carcinoma (cSCC) is the most common skin cancer with metastatic potential, but epidemiologic data are poor. Changes to the National Cancer Registration and Analysis Service (NCRAS) in England have allowed more accurate data analysis of primary and metastatic cSCC since 2013. Objective: To assess the national incidence of cSCC and metastatic cSCC (mcSCC) in England from 2013 through 2015. Design, Setting, and Participants: This national population-based study identified a cohort of patients with cSCC and mcSCC in England from January 1, 2013, through December 31, 2015. Patients were identified using diagnostic codes derived from pathology reports in the NCRAS. Data were analyzed from March 1, 2017, through March 1, 2018. Main Outcomes and Measures: Incidence rates across sex and risk factors for cSCC were derived from the NCRAS data. Risk of occurrence of mcSCC among the population with cSCC was assessed with Cox proportional hazards regression analysis to determine indicators of mcSCC. Results: Among the 76 977 patients with first primary cSCC in 2013 through 2015 (62.7% male; median age, 80 years [interquartile range, 72-86 years]), the age-standardized rates for the first registered cSCC in England from 2013 through 2015 were 77.3 per 100 000 person-years (PY) (95% CI, 76.6-78.0) in male patients and 34.1 per 100 000 PY (95% CI, 33.7-34.5) in female patients. Increased primary cSCC tumor count was observed in older, white male patients in lower deprivation quintiles. After a maximum follow-up of 36 months, cumulative incidence of mcSCC developed in 1.1% of women and 2.4% of men with a primary cSCC. Significant increases in the risk of metastasis with adjusted hazard rates of approximately 2.00 were observed in patients who were aged 80 to 89 years (hazard ratio [HR], 1.23; 95% CI, 1.07-1.43), 90 years or older (HR, 1.35; 95% CI, 1.09-1.66), male (HR, 1.79; 95% CI, 1.52-2.10), immunosuppressed (HR, 1.99; 95% CI, 1.64-2.42), and in higher deprivation quintiles (HR for highest quintile, 1.64; 95% CI, 1.35-2.00). Primary cSCC located on the ear (HR, 1.70; 95% CI, 1.42-2.03) and lip (HR, 1.85; 95% CI, 1.29-2.63) were at highest risk of metastasis. Conclusions and Relevance: This study presents the first national study of the incidence of mcSCC. With limited health care resources and an aging population, accurate epidemiologic data are essential for informing future health care planning, identifying high-risk patients, and evaluating skin cancer prevention policies.

Indexed as

AgedAged, 80 and overAge FactorsCarcinoma, Squamous CellCohort StudiesEnglandFemaleHumansIncidenceMaleNeoplasm MetastasisRisk FactorsSex FactorsSkin Neoplasms

Identifiers

PMID30484823
PMCPMC6521686
OpenAlexW2903383393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.